1Maruyama Y, Feola JM, Tai D, et al. Californium Cf-252 for pelvic radiotherapy. Oncology,1978,35:172-178.
2Yamashita T, Kaneta K, Tsuya A. Update on intracavitary therapy with Cf-252 for uterine cervical carcinoma at Japan Cancer Institute Hospital. Nucl Sci Appl, 1991,4: 193-196.
3Maruyama Y, Feola JM, Wierzbicki J, et al. Clinical study of relative biological effectiveness for cervical carcinoma treated by 252Cf neutrons and assessed by histological tumour eradication. Br J Radiol,1990,63:270-277.
4Ivanov VN, Elisyutin GP, Konar VY. Physical research into Cf-252 for brachytherapy in the USSR. Nucl Sci Appl,1991, 4:379-395.
5Maruyama Y, van Nagell JR, Yoneda J, et al. A review of californium-252 neutron brachytherapy for cervical cancer. Cancer, 1991,68:1189-1197.
6Tacev T, Ptackova B, Strnad V. Californium-252 (252Cf) versus conventional gamma radiation in the brachytherapy of advanced cervical carcinoma long-term treatment results of a randomized study. Strahlenther Onkol, 2003,179:377-384.
7Maruyama Y, Muir W. Human cervical cancer clearance after 252Cf neutron brachytherapy versus conventional photon brachytherapy. Am J Clin Oncol,1984,7:347-352.
8Maruyama Y, Mesina J, Yudelev M, et al. New understanding from Cf brachytherapy trials and considerations for neutron therapy of bulky gyn carcinoma for future. Strahlenther Onkol,1994,170:253-263.
9Toita T, Kakinohana Y, Ogawa K, et al. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule. Int J Radiat Oncol Biol Phys, 2003,56:1344-1353.
10Maruyama Y, van Nagell JR, Yoneda J, et al. Schedule in Cf-252 neutron brachytherapy: complications after delayed implant therapy for cervical cancer in a phase Ⅱ trial. Am J Clin Oncol,1993,16:168-174.
10LEE MY, WU HG, KIM K, et al. Concurrent radiotherapy with paelitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix[J]. Gynecol Oncol, 2007,104( 1 ) : 95-99.
